Uncategorized
Eyes on the Prize: It’s Not the Approval, It’s the Reimbursement
Dear Friends: I apologize for falling behind in sharing any new blogposts in some time. I suppose everyone needs a 2015 Resolution, and mine is to commit to a more regular schedule. Many of you have confronted, hundreds of times, the policy issue that slapped me in the face at the end of the year.…
Read MoreThe Shutdown Ends! Or, does it?
The Shutdown. The cliff. Okay, so the news pundits seem to say it’s over. We have a Continuing Resolution, a reprieve from the Debt Ceiling, and the toddlers on The Hill are acting a little older. But, over? Surely not. Even worse, the impact on healthcare seems far stronger than what I’ve seen in the…
Read MoreCologuard: Who’s really deciding Medicare’s reimbursement?
Cologuard, the whiz-bang colon cancer test from Exact Sciences (EXAS), is the star of quite a three-ring circus in Washington this month. FDA is close to marketing approval, and a parallel track is evaluating Medicare coverage, but most folks are watching the show in the big ring – the price Medicare will pay for the…
Read MorePersonal Note
I try hard to keep blogposts to business topics. Perhaps there’s some way to stretch-h-h that definition to cover one possible change in my general point of view. My first grandchild was born last night. Let’s see if that changes my worldview, particularly my professional cynicism. Let me know what you observe, please. Meanwhile, please…
Read More